» Articles » PMID: 32944946

Post-COVID-19 Inflammatory Syndrome Manifesting As Refractory Status Epilepticus

Overview
Journal Epilepsia
Specialty Neurology
Date 2020 Sep 18
PMID 32944946
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

There have been multiple descriptions of seizures during the acute infectious period in patients with COVID-19. However, there have been no reports of status epilepticus after recovery from COVID-19 infection. Herein, we discuss a patient with refractory status epilepticus 6 weeks after initial infection with COVID-19. Extensive workup demonstrated elevated inflammatory markers, recurrence of a positive nasopharyngeal SARS-CoV-2 polymerase chain reaction, and hippocampal atrophy. Postinfectious inflammation may have triggered refractory status epilepticus in a manner similar to the multisystemic inflammatory syndrome observed in children after COVID-19.

Citing Articles

New-onset refractory status epilepticus after SARS-CoV-2 infection: a review of literature.

Stavropoulos A, Filippou D Croat Med J. 2025; 65(6):510-517.

PMID: 39812100 PMC: 11748445.


Recurrent COVID-19-related psychotic disorder with neuro-immuno-endocrine dysfunction as a possible underlying mechanism: A case report from China.

Yang C, He Y, Yuan L, Yuan C, Chang F, Feng W Brain Behav Immun Health. 2024; 39:100803.

PMID: 39022626 PMC: 466972. DOI: 10.1016/j.bbih.2024.100803.


Long COVID: From olfactory dysfunctions to viral Parkinsonism.

Pandey S, Bapat V, Abraham J, Abraham N World J Otorhinolaryngol Head Neck Surg. 2024; 10(2):137-147.

PMID: 38855289 PMC: 11156689. DOI: 10.1002/wjo2.175.


Post covid seizure.

Renukaprasad A, Basu Roy P, Rao A IDCases. 2024; 36:e01982.

PMID: 38765801 PMC: 11101951. DOI: 10.1016/j.idcr.2024.e01982.


Neurological and Psychiatric Manifestations of Long COVID-19 and Their [F]FDG PET Findings: A Review.

Hameed R, Bahadur A, Singh S, Sher J, Todua M, Moradi L Diagnostics (Basel). 2023; 13(14).

PMID: 37510097 PMC: 10378471. DOI: 10.3390/diagnostics13142353.


References
1.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones C, Shah P . Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA. 2020; 324(3):259-269. PMC: 7281356. DOI: 10.1001/jama.2020.10369. View

2.
Balloy G, Leclair-Visonneau L, Pereon Y, Magot A, Peyre A, Mahe P . Non-lesional status epilepticus in a patient with coronavirus disease 2019. Clin Neurophysiol. 2020; 131(8):2059-2061. PMC: 7217773. DOI: 10.1016/j.clinph.2020.05.005. View

3.
Wang C, Kang K, Gao Y, Ye M, Lan X, Li X . Cytokine Levels in the Body Fluids of a Patient With COVID-19 and Acute Respiratory Distress Syndrome: A Case Report. Ann Intern Med. 2020; 173(6):499-501. PMC: 7224607. DOI: 10.7326/L20-0354. View

4.
Obermeier B, Daneman R, Ransohoff R . Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013; 19(12):1584-96. PMC: 4080800. DOI: 10.1038/nm.3407. View

5.
Dhikav V, Anand K . Hippocampal atrophy may be a predictor of seizures in Alzheimer's disease. Med Hypotheses. 2007; 69(1):234-5. DOI: 10.1016/j.mehy.2006.11.031. View